KR100441644B1 - 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 - Google Patents
참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 Download PDFInfo
- Publication number
- KR100441644B1 KR100441644B1 KR10-2001-7009041A KR20017009041A KR100441644B1 KR 100441644 B1 KR100441644 B1 KR 100441644B1 KR 20017009041 A KR20017009041 A KR 20017009041A KR 100441644 B1 KR100441644 B1 KR 100441644B1
- Authority
- KR
- South Korea
- Prior art keywords
- angelan
- diabetes
- nod mice
- cells
- mice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
- 참당귀에서 분리한 다당류 물질인 안젤란을 유효성분으로 포함하는 당뇨병 예방 및 치료용 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000007138 | 2000-02-15 | ||
KR1020000007138A KR20010081514A (ko) | 2000-02-15 | 2000-02-15 | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010113655A KR20010113655A (ko) | 2001-12-28 |
KR100441644B1 true KR100441644B1 (ko) | 2004-07-23 |
Family
ID=19646692
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000007138A KR20010081514A (ko) | 2000-02-15 | 2000-02-15 | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 |
KR10-2001-7009041A KR100441644B1 (ko) | 2000-02-15 | 2000-08-10 | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000007138A KR20010081514A (ko) | 2000-02-15 | 2000-02-15 | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 |
Country Status (3)
Country | Link |
---|---|
KR (2) | KR20010081514A (ko) |
AU (1) | AU6478900A (ko) |
WO (1) | WO2001060386A1 (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100726006B1 (ko) * | 2005-09-28 | 2007-06-08 | 한국생명공학연구원 | 참당귀 유래 다당류를 유효성분으로 포함하는 암질환 전이 억제용 약학적 조성물 |
KR100746294B1 (ko) * | 2006-06-02 | 2007-08-03 | 한국생명공학연구원 | 참당귀 유래 다당류를 유효성분으로 포함하는 수지상세포활성화용 약학 조성물 |
WO2012021014A2 (ko) * | 2010-08-11 | 2012-02-16 | 제일약품주식회사 | 당귀 추출물 및 산마늘 추출물의 복합조성물을 유효성분으로 함유하는 당뇨병 또는 당뇨 합병증 예방 또는 치료용 조성물 |
WO2017023703A1 (en) * | 2015-07-31 | 2017-02-09 | Sivanaray, Inc. | Compounds, compositions and methods for prevention or treatment of liver and lipid-related conditions |
KR102061048B1 (ko) | 2018-09-03 | 2019-12-31 | 한국식품연구원 | 오미자 및 콩즙을 포함하는 당뇨개선용 식품조성물 및 이의 제조방법 |
-
2000
- 2000-02-15 KR KR1020000007138A patent/KR20010081514A/ko active Search and Examination
- 2000-08-10 KR KR10-2001-7009041A patent/KR100441644B1/ko active IP Right Grant
- 2000-08-10 WO PCT/KR2000/000880 patent/WO2001060386A1/ko active IP Right Grant
- 2000-08-10 AU AU64789/00A patent/AU6478900A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001060386A1 (ko) | 2001-08-23 |
KR20010081514A (ko) | 2001-08-29 |
KR20010113655A (ko) | 2001-12-28 |
AU6478900A (en) | 2001-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Czechowska et al. | Protective effects of melatonin against thioacetamide-induced liver fibrosis in rats | |
Yu et al. | Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice | |
Arise et al. | Lipid profile, antidiabetic and antioxidant activity of Acacia ataxacantha bark extract in streptozotocin-induced diabetic rats | |
Anwer et al. | Antidiabetic potential of Moringa oleifera Lam. leaf extract in type 2 diabetic rats, and its mechanism of action | |
Abd El-Aal et al. | Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-α/MAPKs/RIPK/MLKL/BDNF | |
KR100441644B1 (ko) | 참당귀에서 분리한 다당류의 당뇨병 예방 및 치료용 조성물 | |
Novrial et al. | Protective effect of Ipomoea batatas L leaves extract on histology of pancreatic langerhans islet and beta cell insulin expression of rats induced by streptozotocin | |
Aly et al. | Effect of Egyptian radish and clover sprouts on blood sugar and lipid metabolisms in diabetic rats | |
Alqahtani et al. | Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats | |
KR100441643B1 (ko) | 펠리누스 린테우스에서 분리한 다당류의 당뇨병 예방 및치료용 조성물 | |
El-Far et al. | Promising biopharmaceutical use of silymarin and silibinin as antidiabetic natural agents in streptozotocin-induced diabetic rats: first comparative assessment | |
Mahmoud et al. | Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: imperative roles of AMPK/Akt/CREB/BDNF signaling cascades | |
Bell Jr et al. | Importance of diabetes in inhibition of pancreatic cancer by streptozotocin | |
KR102038887B1 (ko) | 댕댕이나무열매 추출물을 포함하는 비만, 고지혈증 또는 지방간의 예방 또는 치료용 약제학적 조성물 및 이의 제조방법 | |
KR100406848B1 (ko) | 프로디지오신의 당뇨병 예방 및 치료용 조성물 | |
Berdja et al. | Scolymus hispanicus (golden thistle) ameliorates hepatic steatosis and metabolic syndrome by reducing lipid accumulation, oxidative stress, and inflammation in rats under hyperfatty diet | |
Sawiress | Effect of Ginseng extract supplementation on renal functions in diabetic rats | |
Radhika et al. | Effect of the aqueous extract of Sesbania grandiflora Linn in alloxan induced diabetes in albino rats | |
Srivastava et al. | Hypoglycemic effect of polyherbal formulations in alloxan induced diabetic mice | |
Mirsky | Glucose tolerance factor–insulin mimetic and potentiating agent–a source for a novel anti diabetic medication | |
Taiwo et al. | Glycaemic activity of Ficus exasperata in fructose-induced glucose intolerance in rats | |
RU2390348C1 (ru) | Средство "стабинорм" для лечения синдрома хронической усталости | |
Tchamadeu et al. | Pterocarpus soyauxii Taub (Papilionaceae) Aqueous Stem Bark Extract Prevents Dexamethasone-induced Insulin Resistance and Oxidative Stress in Rat | |
Samy et al. | Effect of Prunetin on Streptozotocin-Induced Diabetic Nephropathy in Rats-a Biochemical and Molecular Approach | |
KR102136484B1 (ko) | 간 손상 예방 또는 치료용 조성물 및 그 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130704 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140707 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150615 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160701 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170627 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180531 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190522 Year of fee payment: 16 |